| For: | Benítez JM, García-Sánchez V. Faecal calprotectin: Management in inflammatory bowel disease. World J Gastrointest Pathophysiol 2015; 6(4): 203-209 [PMID: 26600978 DOI: 10.4291/wjgp.v6.i4.203] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v6/i4/203.htm |
| Number | Citing Articles |
| 1 |
Mette Esbjørn, Tina Okdahl, Jan Fallingborg, Pernille Larsen, Dorte Vind Andersen, Asbjørn Mohr Drewes, Tine Jess, Lone Larsen. Digitally supported, patient-initiated care: Maintaining control of inflammatory bowel diseases while achieving high patient satisfaction. International Journal of Medical Informatics 2026; 218 doi: 10.1016/j.ijmedinf.2026.106536
|
| 2 |
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterología y Hepatología (English Edition) 2020; 43(1) doi: 10.1016/j.gastre.2019.08.005
|
| 3 |
Ella Serrano, Jean-Philippe Bastard, Laurence Trystram, Soraya Fellahi, Hedi A. Soula, Sophie Thenet, Jean-Michel Oppert, Karine Clément, Christine Poitou, Laurent Genser. Serum Versus Fecal Calprotectin Levels in Patients with Severe Obesity Before and 6 Months After Roux-Y-Gastric Bypass: Report of the Prospective Leaky-Gut Study. Obesity Surgery 2023; 33(12) doi: 10.1007/s11695-023-06911-w
|
| 4 |
Joao Paulo Steffens, Ekin Yay‐Kus, Rafael Scaf de Molon, Viorelia Stoica, Peter Rimmer, Josefine Hirschfeld, Asif Jilani Iqbal, Tariq Iqbal, Iain Chapple. The role of neutrophils in the pathophysiology of inflammatory bowel diseases. Periodontology 2000 2025; 99(1) doi: 10.1111/prd.70037
|
| 5 |
Sebastián Eduardo Ibáñez Vodnizza, María Paz Poblete De La Fuente, Elisa Catalina Parra Cancino. Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease. Rheumatic Disease Clinics of North America 2020; 46(2) doi: 10.1016/j.rdc.2020.01.004
|
| 6 |
E. Klang, U. Kopylov, R. Eliakim, N. Rozendorn, D. Yablecovitch, A. Lahat, S. Ben-Horin, M.M. Amitai. Diffusion-weighted imaging in quiescent Crohn's disease: correlation with inflammatory biomarkers and video capsule endoscopy. Clinical Radiology 2017; 72(9) doi: 10.1016/j.crad.2017.04.006
|
| 7 |
Anet A. Soubières, Andrew Poullis. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2016; 22(8) doi: 10.1097/MIB.0000000000000836
|
| 8 |
Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Reem Elbeltagi. Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons. World Journal of Clinical Pediatrics 2024; 13(2): 93341 doi: 10.5409/wjcp.v13.i2.93341
|
| 9 |
Laurent Genser, Doriane Aguanno, Hédi A Soula, Liping Dong, Laurence Trystram, Karen Assmann, Joe‐Elie Salem, Jean‐Christophe Vaillant, Jean‐Michel Oppert, Fabienne Laugerette, Marie‐Caroline Michalski, Philippe Wind, Monique Rousset, Edith Brot‐Laroche, Armelle Leturque, Karine Clément, Sophie Thenet, Christine Poitou. Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes. The Journal of Pathology 2018; 246(2) doi: 10.1002/path.5134
|
| 10 |
Shahzeb Saeed, Chukwuyem Ekhator , Ali M Abdelaziz, Husnain Naveed, Amanda Karski , Daniel E Cook, Shivani M Reddy, Maryam Affaf, Salman J Khan, Sophia B Bellegarde, Abdur Rehman , Abdul Haseeb Hasan, Abdullah Shehryar. Revolutionizing Inflammatory Bowel Disease Management: A Comprehensive Narrative Review of Innovative Dietary Strategies and Future Directions. Cureus 2023; doi: 10.7759/cureus.44304
|
| 11 |
Farahnaz Joukar, Hadi Mohsenifar, Saman Maroufizadeh, Milad Shahdkar, Mahdi Orang Goorabzarmakhi, Mahmoud Khoshsorour, Fariborz Mansour-Ghanaei. Assessment of calprotectin levels preceding and succeeding colonoscopy. Gastrointestinal Nursing 2024; 22(10) doi: 10.12968/gasn.2024.0021
|
| 12 |
Fernando Magro, Joana Afonso, Susana Lopes, Rosa Coelho, Raquel Gonçalves, Paulo Caldeira, Paula Lago, Helena Tavares de Sousa, Jaime Ramos, Ana Rita Gonçalves, Paula Ministro, Isadora Rosa, Ana Isabel Vieira, Patrícia Andrade, João-Bruno Soares, Diana Carvalho, Paula Sousa, Tânia Meira, Joanne Lopes, Joana Moleiro, Cláudia Camila Dias, Amílcar Falcão, Karel Geboes, Fatima Carneiro. Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation. EBioMedicine 2017; 21 doi: 10.1016/j.ebiom.2017.06.004
|
| 13 |
Anuraag Jena, Vishal Sharma, Usha Dutta. Fecal calprotectin in cirrhosis—Does “ESR” of the intestine measure the liver dysfunction too?. Indian Journal of Gastroenterology 2023; 42(6) doi: 10.1007/s12664-023-01481-2
|
| 14 |
Maxime M.W. De Sloovere, Dieter De Smet, Filip J. Baert, Johan Debrabandere, Hilde J.M. Vanpoucke. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease. Clinical Chemistry and Laboratory Medicine (CCLM) 2017; 55(9) doi: 10.1515/cclm-2016-0796
|
| 15 |
Efstathia Papada, Charalampia Amerikanou, Aristea Gioxari, Nick Kalogeropoulos, Andriana C. Kaliora. The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative Colitis. Diagnostics 2020; 10(10) doi: 10.3390/diagnostics10100798
|
| 16 |
Grazyna Piotrowicz, Agnieszka Klufczyńska, Jacek Kowerzanow, Piotr Banaszkiewicz,, Grażyna Rydzewska. Crohn’s disease activity evaluation based on imaging studies and biomarkers. Gastroenterology & Hepatology: Open Access 2018; 9(2) doi: 10.15406/ghoa.2018.09.00292
|
| 17 |
Sihem Ait‐Oudhia, Yi Ting (Kayla) Lien, Sumit Basu, Lawrence Lesko, Stephan Schmidt. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. 2019; doi: 10.1002/9781119289234.ch10
|
| 18 |
. 2017; doi: 10.70675/b31dde1bz1941z4398zaa56z406e97d709fa
|
| 19 |
Hong Bao, Chen Yang, Panrui Zhang, Jiayang Zhang, Siyao Fang, Alin Yang, Zhentao Yang, Siwen Wang, Si Chen, Xuebiao Yao, Kaiguang Zhang, Shu Zhu, Dan Cao, Wen Pan. A gut-secreted histidine methyltransferase enforces cross-kingdom catalytic antifungal defense. Cell Host & Microbe 2026; 34(1) doi: 10.1016/j.chom.2025.11.015
|
| 20 |
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterología y Hepatología 2020; 43(1) doi: 10.1016/j.gastrohep.2019.08.011
|
| 21 |
Vanesa Jusué, María Chaparro, Javier P. Gisbert. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease. Digestive and Liver Disease 2018; 50(4) doi: 10.1016/j.dld.2017.12.022
|
| 22 |
Khushboo G. Upadhyay, Devendra C. Desai, Tester F. Ashavaid, Alpa J. Dherai. Evaluating the role of kynurenine/tryptophan ratio as an indicator of disease activity in Indian patients with inflammatory bowel disease. A case-control study. Scandinavian Journal of Gastroenterology 2025; 60(5) doi: 10.1080/00365521.2025.2491784
|
| 23 |
Stelios Pavlidis, Calixte Monast, Matthew J. Loza, Patrick Branigan, Kiang F. Chung, Ian M. Adcock, Yike Guo, Anthony Rowe, Frédéric Baribaud, Atle van Beelen Granlund. I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment. PLOS Computational Biology 2019; 15(4) doi: 10.1371/journal.pcbi.1006951
|
| 24 |
Joško Osredkar, Nina Ekart, David Drobne. Calprest ELISA vs. Liaison® Chemiluminescence: Evaluating Accuracy, Efficiency, and Clinical Utility in Fecal Calprotectin Testing. Biomedicines 2026; 14(1) doi: 10.3390/biomedicines14010143
|
| 25 |
Marisa Iborra, Belén Beltrán, Pilar Nos. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 2016; 26(4) doi: 10.1016/j.giec.2016.06.005
|
| 26 |
. 2020; doi: 10.70675/b56c7041z5357z4f20z9868z8dd1575778ce
|
| 27 |
Lili Wei, Mingwen Liu, Haofei Xiong. Role of Calprotectin as a Biomarker in Periodontal Disease. Mediators of Inflammation 2019; 2019 doi: 10.1155/2019/3515026
|
| 28 |
Alexandre Jentzer, Anne-Emmanuelle Depincé-Berger, Christian Genin, Xavier Roblin, Stéphane Paul. Nouveaux marqueurs diagnostiques et pronostiques des maladies chroniques inflammatoires intestinales. Revue Francophone des Laboratoires 2016; 2016(484) doi: 10.1016/S1773-035X(16)30223-4
|
| 29 |
Milena Peruhova, Daniela Stoyanova, Dimitrina Georgieva Miteva, Meglena Kitanova, Milko Bozhidarov Mirchev, Tsvetelina Velikova. Genetic factors that predict response and failure of biologic therapy in inflammatory bowel disease. World Journal of Experimental Medicine 2025; 15(1): 97404 doi: 10.5493/wjem.v15.i1.97404
|
| 30 |
Kata Judit Szántó, Tamara Madácsy, Diána Kata, Tamás Ferenci, Mariann Rutka, Anita Bálint, Renáta Bor, Anna Fábián, Ágnes Milassin, Boldizsár Jójárt, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Imre Földesi, József Maléth, Klaudia Farkas. Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists. Expert Opinion on Biological Therapy 2021; 21(4) doi: 10.1080/14712598.2021.1890712
|
| 31 |
Manoj Kumar, Selvasankar Murugesan, Nazira Ibrahim, Mamoun Elawad, Souhaila Al Khodor. Predictive biomarkers for anti-TNF alpha therapy in IBD patients. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05058-1
|
| 32 |
Chen Sarbagili-Shabat, Shira Zelber-Sagi, Naomi Fliss Isakov, Ayal Hirsch, Yulia Ron, Laura Sol Grinshpan, Nathaniel Aviv Cohen, Haim Leibovitzh, Tamar Thurm, Nitsan Maharshak. High Ultra-Processed Food Consumption Is Associated with Clinical Exacerbation in Patients with Crohn’s Disease in Remission: A Prospective Cohort Study. Digestive Diseases 2025; 43(4) doi: 10.1159/000546486
|